AMCA
AGIO icon

Arthur M. Cohen & Associates’s Agios Pharmaceuticals AGIO Stock Holding History

Arthur M. Cohen & Associates’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,171
Closed -$111K – 143
2020
Q3 		$111K Buy
+3,171
New +$139K 0.03% 135
2019
Q2 		– Sell
-7,612
Closed -$513K – 117
2019
Q1 		$513K Hold
7,612
– – 0.18% 71
2018
Q4 		$587 Hold
7,612
– – 0.19% 67
2018
Q3 		$587 Hold
7,612
– – 0.18% 71
2018
Q2 		$641K Hold
7,612
– – 0.24% 61
2018
Q1 		$560K Hold
7,612
– – 0.21% 65
2017
Q4 		$351 Buy
+7,612
New +$479K 0.1% 83
2017
Q2 		$397K Buy
+7,612
New +$389K 0.16% 77
2014
Q3 		$508K Buy
+7,612
New +$328K 0.24% 71

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return